Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$EMED Despite the benefits of a diverse consumer drug market for pain managment, the non-medical use of pharmaceutical opioids has triggered new health threats & an escalating drug abuse epidemic.
$EMED When it comes to electricity created in the human body, the energy source is chemical and has to do with the composition of the atoms and molecules present. All the elements we take into our bodies, such as oxygen, sodium, potassium, calcium, magnesium etc., have a specific electrical charge. How those molecules are bound together and how they react to other molecules near them is how chemicals create energy. Some of these electrical impulses found naturally in our bodies activate functions needed for healing.
$EMED Our mission
Over 80 million Americans live with moderate to severe pain resulting from an accident or a disease, nearly 40% of them report being unable to find adequate pain relief and 77% report feeling depressed due to their chronic pain.
Our goal is to unlock the body’s natural ability to achieve wellness through high performance electrotherapy technologies, using energy, frequency and vibrations to improve quality of life.
Activists of a drug free approach, we take prescription drug misuse very seriously.
Alarming statistics have highlighted the importance of an alternative method for pain management.
https://electromedtech.com/our-mission/
$EBYH Low Float. Check out latest news. App health tech and March news could be a bitcoin mining deal, as their neighbor just financed a 300 million dollar deal with Talen Energy.
$NBIO Phase I reinforced the companies' determination and excitement around this unique monoclonal antibody treatment approach and Phase I has shown that it can be given safely at high doses. This is a new pathway toward attacking one of the defining health challenges we face, with longer-term implications that transcend the brain cancer market. We look forward to the opportunity to see our unique R&D platform become a game changer for patients suffering from brain cancer.
$PVSP News and Headlines https://www.barchart.com/stocks/quotes/PVSP/news
$PVSP 100 M shares of Common Stock with NO Debt, No Convertibles, No Special Series Stock, simple and clean share structure, every shareholder get the same type of Common Stock with one vote per share, as it should be.
If you own 1% of PVSP, you will get 1% ownership in Artizen Spin Off. Totally Fair and straight forward
$PVSP Built a solid finance and accounting infrastructure.
$GBHL
$PVSP Weed legalization is already supported by most U.S. voters. And in November, a poll released by Winthrop University(opens in new tab) found that 78% of adults in South Carolina, including a majority of Republicans, would like to see medical cannabis reform. An additional 54% of voters were in favor of recreational weed legalization.
$PVSP Taken $1 million in debt off the books.
$GBHL
$PVSP is working hard as well to build value to shareholders.
$PVSP Built a solid finance and accounting infrastructure.
$GBHL
$PVSP is working hard as well to build value to shareholders.
$PVSP The current team has cleaned up the business.
$PVSP The current team has cleaned up the business.
$GBHL
$HTSC Overview https://www.otcmarkets.com/stock/HTSC/overview
$PVSP Taken $1 million in debt off the books.
$GBHL
$PVSP Pervasip Corp will still be managed by the current executive management team.
$PVSP Built a solid finance and accounting infrastructure.
$PVSP Weed legalization is already supported by most U.S. voters. And in November, a poll released by Winthrop University(opens in new tab) found that 78% of adults in South Carolina, including a majority of Republicans, would like to see medical cannabis reform. An additional 54% of voters were in favor of recreational weed legalization.
$PVSP Taken $1 million in debt off the books.
$PVSP Pervasip common shareholders will receive 15% or 15,000,000 shares in Artizen Corp at the Record Date
The Record Date is the day end of day before the date at which the new Artizen Ticker goes life
Pervasip are not shortchanged. On an as if fully diluted basis, all Pervasip common shares amount to approximately 13.8% of all outstanding shares; we set 15% aside for all common shareholders in Artizen Corp
$PVSP Built a solid finance and accounting infrastructure.
$PVSP Burtscher added,
“Timing is important. The valuations and fates of MSOs and other participants in the cannabis industry have vacillated in several waves since state legalization commenced. We believe that increased legalization is inevitable in time, both at the federal level and in the form of improved regulatory environments in Washington. Preparing ourselves for that day is an important aspect of our long-term plans, including by expanding our brands and building on our footprint in valuable new geographies, and accessing long term equity capital to do so with shareholder friendly structures. Critically, the Artizen capital structure after the spin-out is completed has been specifically designed to allow us to raise equity financing on terms that vastly exceed anything that we can accomplish with Pervasip’s current capital structure.”[
$PVSP Taken $1 million in debt off the books.
$PVSP ZAM provides consulting, leasing, intellectual property licensing and other long-term arrangements to cannabis operators, including management of the Artizen™ brand assets
https://www.pervasip.net/zen-asset-management-zam
$PVSP Built a solid finance and accounting infrastructure.
$PVSP Pervasip Corp., a developer of companies and technologies in high value emerging markets, owns Artizen Corporation and its subsidiary, Zen Asset Management LLC, a diversified asset management company founded to acquire, develop, and support companies and technologies in the cannabis industry. ZAM’s existing clients operate four licensed cannabis cultivation and one processing facility in Washington. Most of the biomass produced by these independent cultivators has been sold historically under the Artizen™ brand, including all-time top selling products in flower in Washington state. Additional information on Artizen-branded products is available online at www.artizencannabis.com. Pervasip additionally owns 5% of KRTL Biotech, Inc., a developer of biotechnologies with a focus on pharmaceutical applications of cannabinol and psilocybin. Additional information on KRTL is available online at www.krtlbiotech.com.
$PVSP SEATTLE, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” and the “Company”) today announced that it will spin-off 100% of its wholly-owned subsidiary, Artizen Corporation (“Artizen”), as a separate public company, with an anticipated record date between July 1, 2023, and September 30, 2023. As a result of the spin-off, all Pervasip shareholders of record as of the designated record date shall receive shares in the newly public Artizen in proportion to their ownership in Pervasip. Artizen conducts 100% of Pervasip’s cannabis business segment operations through its Zen Asset Management LLC subsidiary ("Zen”).
https://www.nasdaq.com/press-release/pervasip-announces-artizen-spin-off-2023-01-17
$PVSP Holders of Pervasip’s issued and outstanding common shares as of the record date will receive an aggregate of 15,000,000 shares of Artizen common stock, corresponding to 15% of Artizen’s fully diluted issued and outstanding common shares upon completion of the transaction (in addition to retaining their shares in Pervasip). Likewise, holders of Pervasip’s Series K and other convertible securities will receive an aggregate of 85,000,000 shares of Artizen common stock, the vast majority of which will be subject to lock-up restrictions prohibiting sales prior to Artizen’s realization of material growth and other performance objectives. Artizen will have 100,000,000 common shares outstanding on a fully diluted basis upon completion of the transaction, with no convertible debt or other securities.
$PVSP The Company is working with its auditors to complete the required financial audits, including one for Pervasip on a consolidated basis and another for Artizen on a consolidated basis (without Pervasip). Once complete, a Form 10 Registration Statement will be filed with the SEC for Artizen to initiate the spin-off process. Additional information regarding the status and timing of the transaction and the various required regulatory and other approvals will be provided as it becomes available. Pervasip has commenced evaluation of potential targets for acquisition upon completion of the Artizen spin-off.
$PVSP The current team has cleaned up the business.
$PVSP Pervasip currently has about 5,000,000,000 shares of common stock issued and outstanding, corresponding to about 15% of Pervasip’s fully diluted issued and outstanding common stock. Pervasip additionally has 850,000 shares of Series K convertible preferred stock issued and outstanding, corresponding to 85% of Pervasip’s fully diluted issued and outstanding common stock, as well as various other convertible securities.
https://www.morningstar.com/news/globe-newswire/8730826/pervasip-announces-artizen-spin-off
$PVSP The Company is working with its auditors to complete the required financial audits, including one for Pervasip on a consolidated basis and another for Artizen on a consolidated basis (without Pervasip). Once complete, a Form 10 Registration Statement will be filed with the SEC for Artizen to initiate the spin-off process. Additional information regarding the status and timing of the transaction and the various required regulatory and other approvals will be provided as it becomes available. Pervasip has commenced evaluation of potential targets for acquisition upon completion of the Artizen spin-off.
$PVSP The Company is working with its auditors to complete the required financial audits, including one for Pervasip on a consolidated basis and another for Artizen on a consolidated basis (without Pervasip). Once complete, a Form 10 Registration Statement will be filed with the SEC for Artizen to initiate the spin-off process. Additional information regarding the status and timing of the transaction and the various required regulatory and other approvals will be provided as it becomes available. Pervasip has commenced evaluation of potential targets for acquisition upon completion of the Artizen spin-off.
The CEO of $UATG has a lot of impressive videos on their website......well worth watching:
http://www.uatgroup.com/
Latest:
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
$MASN Follow On Twitter
https://twitter.com/MaisonLuxeInc
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
$PVSP will provide a group of BCCTG owners, investors and employees 10.2% of Pervasip’s fully diluted equity in the form of restricted preferred stock.
$PVSP will provide a group of BCCTG owners, investors and employees 10.2% of Pervasip’s fully diluted equity in the form of restricted preferred stock.
$MASN trading 55% of its 10-day average volume so far this morning... UP almost 7% on today's News.
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
$PVSP is another gem with a MC of 6-7mil but making $20+ mil with a positive ebitda.
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
$PVSP Twitter status update: https://twitter.com/PervasipC
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
Followers
|
168
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
10584
|
Created
|
01/23/11
|
Type
|
Free
|
Moderator stock zombie | |||
Assistants balamidas Trooperstocks fast.money |
LOOKING FOR THE NEXT BIG RUNNER
"WE ARE ON A MISSION TO FIND THE HIDDEN TREASURE"
NUCLEAR Stock Picks
Click on picture to visit board
>>> CLICK HERE<<<
To sign up for NUCLEAR Stock Picks
Instructions how to use the IHUB Advanced Search feature
To get stocks to appear on The Buzz Cloud
Visit our sister board:
CLICK HERE TO BOARDMARK: LOOKING FOR THE NEXT BIG RUNNER
BOARD DISCLAIMER
StockTradersTalk
SubbiesReady2Go
Moderator: Day Trading Assistants: balamidas, jedijazz, stockfalcon, tommyboyboy
Posts Today
|
0
|
Posts (Total)
|
10584
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |